MERCK & CO INC
10-Q, EX-27, 2000-08-10
PHARMACEUTICAL PREPARATIONS
Previous: MERCK & CO INC, 10-Q, EX-12, 2000-08-10
Next: MERCURY GENERAL CORP, 10-Q, 2000-08-10



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY  FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED STATEMENT OF INCOME FOR THE SIX MONTHS ENDED JUNE 30, 2000 AND THE
CONSOLIDATED BALANCE SHEET AS OF JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           2,806
<SECURITIES>                                     1,106
<RECEIVABLES>                                    3,863
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                      2,928
<CURRENT-ASSETS>                                11,841
<PP&E>                                          15,410
<DEPRECIATION>                                 (5,004)
<TOTAL-ASSETS>                                  37,443
<CURRENT-LIABILITIES>                            9,048
<BONDS>                                          3,439
                                0
                                          0
<COMMON>                                            30
<OTHER-SE>                                      12,689
<TOTAL-LIABILITY-AND-EQUITY>                    37,443
<SALES>                                         18,328
<TOTAL-REVENUES>                                18,328
<CGS>                                            9,920
<TOTAL-COSTS>                                    9,920
<OTHER-EXPENSES>                                 1,072
<LOSS-PROVISION>                                     0<F1>
<INTEREST-EXPENSE>                                 233
<INCOME-PRETAX>                                  4,671
<INCOME-TAX>                                     1,450
<INCOME-CONTINUING>                              3,221
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,221
<EPS-BASIC>                                       1.39
<EPS-DILUTED>                                     1.37
<FN>
<F1>NOT MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS.
</FN>




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission